rs10494541
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001205293.3(CACNA1E):c.951+553A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.821 in 152,168 control chromosomes in the GnomAD database, including 52,215 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.82 ( 52215 hom., cov: 32)
Consequence
CACNA1E
NM_001205293.3 intron
NM_001205293.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.700
Publications
5 publications found
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 69Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.954 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1E | NM_001205293.3 | c.951+553A>G | intron_variant | Intron 6 of 47 | ENST00000367573.7 | NP_001192222.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1E | ENST00000367573.7 | c.951+553A>G | intron_variant | Intron 6 of 47 | 1 | NM_001205293.3 | ENSP00000356545.2 | |||
| CACNA1E | ENST00000360108.7 | c.951+553A>G | intron_variant | Intron 6 of 46 | 5 | ENSP00000353222.3 | ||||
| CACNA1E | ENST00000367570.6 | c.951+553A>G | intron_variant | Intron 6 of 46 | 1 | ENSP00000356542.1 | ||||
| CACNA1E | ENST00000621791.4 | c.951+553A>G | intron_variant | Intron 6 of 45 | 1 | ENSP00000481619.1 | ||||
| CACNA1E | ENST00000524607.6 | c.1386+553A>G | intron_variant | Intron 8 of 11 | 5 | ENSP00000432038.2 |
Frequencies
GnomAD3 genomes AF: 0.821 AC: 124779AN: 152050Hom.: 52183 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
124779
AN:
152050
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.821 AC: 124864AN: 152168Hom.: 52215 Cov.: 32 AF XY: 0.825 AC XY: 61431AN XY: 74422 show subpopulations
GnomAD4 genome
AF:
AC:
124864
AN:
152168
Hom.:
Cov.:
32
AF XY:
AC XY:
61431
AN XY:
74422
show subpopulations
African (AFR)
AF:
AC:
26881
AN:
41468
American (AMR)
AF:
AC:
13477
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
3219
AN:
3472
East Asian (EAS)
AF:
AC:
5063
AN:
5186
South Asian (SAS)
AF:
AC:
4064
AN:
4818
European-Finnish (FIN)
AF:
AC:
9423
AN:
10614
Middle Eastern (MID)
AF:
AC:
253
AN:
292
European-Non Finnish (NFE)
AF:
AC:
59868
AN:
67998
Other (OTH)
AF:
AC:
1770
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1060
2120
3180
4240
5300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3113
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.